{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,5]],"date-time":"2026-02-05T22:28:54Z","timestamp":1770330534106,"version":"3.49.0"},"reference-count":24,"publisher":"Japanese Society of Internal Medicine","issue":"9","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intern. Med."],"published-print":{"date-parts":[[2024,5,1]]},"DOI":"10.2169\/internalmedicine.2703-23","type":"journal-article","created":{"date-parts":[[2024,2,18]],"date-time":"2024-02-18T22:13:10Z","timestamp":1708294390000},"page":"1197-1205","source":"Crossref","is-referenced-by-count":1,"title":["Impact of the State of Emergency Declaration for Severe Acute Respiratory Syndrome Coronavirus-2 Pandemic Suppression on Individuals with Type 1 Diabetes Mellitus"],"prefix":"10.2169","volume":"63","author":[{"given":"Shota","family":"Mochizuki","sequence":"first","affiliation":[{"name":"Division of Diabetology and Metabolism, Department of Internal Medicine, Tokyo Women&apos;s Medical University School of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Junnosuke","family":"Miura","sequence":"additional","affiliation":[{"name":"Division of Diabetology and Metabolism, Department of Internal Medicine, Tokyo Women&apos;s Medical University School of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Satoshi","family":"Takagi","sequence":"additional","affiliation":[{"name":"Division of Diabetology and Metabolism, Department of Internal Medicine, Tokyo Women&apos;s Medical University School of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mikako","family":"Takita","sequence":"additional","affiliation":[{"name":"Division of Diabetology and Metabolism, Department of Internal Medicine, Tokyo Women&apos;s Medical University School of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroko","family":"Takaike","sequence":"additional","affiliation":[{"name":"Division of Diabetology and Metabolism, Department of Internal Medicine, Tokyo Women&apos;s Medical University School of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tetsuya","family":"Babazono","sequence":"additional","affiliation":[{"name":"Division of Diabetology and Metabolism, Department of Internal Medicine, Tokyo Women&apos;s Medical University School of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"962","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Amengual O, Atsumi T. COVID-19 pandemic in Japan. Rheumatol Int 41: 1-5, 2021.","DOI":"10.1007\/s00296-020-04744-9"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Kishimoto M, Noda M. Diabetes care: after the Great East Japan Earthquake. J Diabetes Investig 4: 97-102, 2013.","DOI":"10.1111\/jdi.12025"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Yagome S, Sugiyama T, Inoue K, et al. Influence of the COVID-19 pandemic on overall physician visits and telemedicine use among patients with type 1 or type 2 diabetes in Japan. J Epidemiol 32: 476-482, 2022.","DOI":"10.2188\/jea.JE20220032"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Hosomi Y, Munekawa C, Hashimoto Y, et al. The effect of COVID-19 pandemic on the lifestyle and glycemic control in individuals with type 1 diabetes: a retrospective cohort study. Diabetol Int 13: 85-90, 2022.","DOI":"10.1007\/s13340-021-00507-4"},{"key":"5","doi-asserted-by":"publisher","unstructured":"5. Sakamoto M, Matsutani D, Minato S, et al. Seasonal variations in the achievement of guideline targets for HbA1c, blood pressure, and cholesterol among patients with type 2 diabetes: a nationwide population-based study (ABC Study: JDDM49). Diabetes Care 42: 816-823, 2019.","DOI":"10.2337\/dc18-1953"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Sakura H, Tanaka Y, Iwamoto Y. Seasonal fluctuations of glycated hemoglobin levels in Japanese diabetic patients. Diabetes Res Clin Pract 88: 65-70, 2010.","DOI":"10.1016\/j.diabres.2009.12.011"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Advani A. Positioning time in range in diabetes management. Diabetologia 63: 242-252, 2020.","DOI":"10.1007\/s00125-019-05027-0"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Gabbay MAL, Rodacki M, Calliari LE, et al. Time in range: a new parameter to evaluate blood glucose control in patients with diabetes. Diabetol Metab Syndr 12: 22, 2020.","DOI":"10.1186\/s13098-020-00529-z"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Sheng X, Xiong GH, Yu PF, Liu JP. The correlation between time in range and diabetic microvascular complications utilizing information management platform. Int J Endocrinol 2020: 8879085, 2020.","DOI":"10.1155\/2020\/8879085"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Eberle C, Stichling S. Impact of COVID-19 lockdown on glycemic control in patients with type 1 and type 2 diabetes mellitus: a systematic review. Diabetol Metab Syndr 13: 95, 2021.","DOI":"10.1186\/s13098-021-00705-9"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Ruegsegger GN, Booth FW. Health benefits of exercise. Cold Spring Harb Perspect Med 8: a029694, 2018.","DOI":"10.1101\/cshperspect.a029694"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Sampath Kumar A, Maiya AG, Shastry BA, et al. Exercise and insulin resistance in type 2 diabetes mellitus: a systematic review and meta-analysis. Ann Phys Rehabil Med 62: 98-103, 2019.","DOI":"10.1016\/j.rehab.2018.11.001"},{"key":"13","doi-asserted-by":"publisher","unstructured":"13. Colberg SR, Sigal RJ, Yardley JE, et al. Physical activity\/exercise and diabetes: a position statement of the American Diabetes Association. Diabetes Care 39: 2065-2079, 2016.","DOI":"10.2337\/dc16-1728"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Chimen M, Kennedy A, Nirantharakumar K, Pang TT, Andrews R, Narendran P. What are the health benefits of physical activity in type 1 diabetes mellitus? A literature review. Diabetologia 55: 542-551, 2012.","DOI":"10.1007\/s00125-011-2403-2"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Hosomi Y, Munekawa C, Hashimoto Y, et al. The effect of COVID-19 pandemic on the lifestyle and glycemic control in patients with type 1 diabetes: a retrospective cohort study. Diabetol Int 13: 85-90, 2022.","DOI":"10.1007\/s13340-021-00507-4"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Depner CM, Melanson EL, Eckel RH, et al. <i>Ad libitum<\/i> weekend recovery sleep fails to prevent metabolic dysregulation during a repeating pattern of insufficient sleep and weekend recovery sleep. Curr Biol 29: 957-967.e4, 2019.","DOI":"10.1016\/j.cub.2019.01.069"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Lee SWH, Ng KY, Chin WK. The impact of sleep amount and sleep quality on glycemic control in type 2 diabetes: a systematic review and meta-analysis. Sleep Med Rev 31: 91-101, 2017.","DOI":"10.1016\/j.smrv.2016.02.001"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Keskin A, \u00dcnalacak M, Bilge U, et al. Effects of sleep disorders on hemoglobin A1c levels in type 2 diabetic patients. Chin Med J (Engl) 128: 3292-3297, 2015.","DOI":"10.4103\/0366-6999.171415"},{"key":"19","doi-asserted-by":"publisher","unstructured":"19. Borel AL, P\u00e9pin JL, Nasse L, Baguet JP, Netter S, Benhamou PY. Short sleep duration measured by wrist actimetry is associated with deteriorated glycemic control in type 1 diabetes. Diabetes Care 36: 2902-2908, 2013.","DOI":"10.2337\/dc12-2038"},{"key":"20","doi-asserted-by":"publisher","unstructured":"20. Ohkuma T, Ide H, Fujii H, et al. Impact of sleep duration on obesity and the glycemic level in patients with type 2 diabetes: the Fukuoka Diabetes Registry. Diabetes Care 36: 611-617, 2013.","DOI":"10.2337\/dc12-0904"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. Ruissen MM, Regeer H, Landstra CP, et al. Increased stress, weight gain and less exercise in relation to glycemic control in people with type 1 and type 2 diabetes during the COVID-19 pandemic. BMJ Open Diabetes Res Care 9: e002035, 2021.","DOI":"10.1136\/bmjdrc-2020-002035"},{"key":"22","doi-asserted-by":"publisher","unstructured":"22. Ruiz-Roso MB, Knott-Torcal C, Matilla-Escalante DC, et al. COVID-19 lockdown and changes of the dietary pattern and physical activity habits in a cohort of patients with type 2 diabetes mellitus. Nutrients 12: 2327, 2020.","DOI":"10.3390\/nu12082327"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23. Aragona M, Rodia C, Bertolotto A, et al. Type 1 diabetes and COVID-19: the &quot;lockdown effect&quot; . Diabetes Res Clin Pract 170: 108468, 2020.","DOI":"10.1016\/j.diabres.2020.108468"},{"key":"24","doi-asserted-by":"publisher","unstructured":"24. Surwit RS, Schneider MS, Feinglos MN. Stress and diabetes mellitus. Diabetes Care 15: 1413-1422, 1992.","DOI":"10.2337\/diacare.15.10.1413"}],"container-title":["Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/63\/9\/63_2703-23\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,4]],"date-time":"2024-05-04T03:30:51Z","timestamp":1714793451000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/63\/9\/63_2703-23\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5,1]]},"references-count":24,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2024]]}},"URL":"https:\/\/doi.org\/10.2169\/internalmedicine.2703-23","relation":{},"ISSN":["0918-2918","1349-7235"],"issn-type":[{"value":"0918-2918","type":"print"},{"value":"1349-7235","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,5,1]]},"article-number":"2703-23"}}